Back to Journals » Breast Cancer: Targets and Therapy » Nanoparticles for Breast Cancer Treatment
Breast Cancer: Targets and Therapy
- View all (732)
- Volume 18, 2026 (81)
- Volume 17, 2025 (104)
- Volume 16, 2024 (76)
- Volume 15, 2023 (79)
- Volume 14, 2022 (41)
- Volume 13, 2021 (58)
- Volume 12, 2020 (27)
- Volume 11, 2019 (32)
- Volume 10, 2018 (24)
- Volume 9, 2017 (64)
- Volume 8, 2016 (26)
- Volume 7, 2015 (36)
- Volume 6, 2014 (20)
- Volume 5, 2013 (13)
- Volume 4, 2012 (22)
- Volume 3, 2011 (16)
- Volume 2, 2010 (9)
- Volume 1, 2009 (4)
Journal Articles:
- Nanoparticles for Breast Cancer Treatment (1)
- Antibody-Drug Conjugates for Breast Cancer Treatment (1)
- Targeting Triple-Negative Breast Cancers: Modern Advancements and Future Directions (4)
- Aging and microenvironment in breast cancer (5)
Nanoparticles for Breast Cancer Treatment
Breast cancer continues to be a significant worldwide health concern. The recent development of targeted treatments has transformed breast cancer therapy, providing more precise and successful strategies by tailoring interventions to the distinct genetic and molecular attributes of individual tumors. The application of nanoparticles for breast cancer treatment is similarly poised to bring about further breakthroughs in breast cancer treatments.
Dual Receptor Targeting Ensures Uptake and Anticancer Efficacy of Low-Density Lipoprotein-Docosahexaenoic Acid Nanoparticles Across Breast Cancer Cell Subtypes
Bower J, Anwar A, Chaudhary J, Chen Z, Schumacher M, Debose-Boyd R, Corbin IR
Breast Cancer: Targets and Therapy 2025, 17:1159-1182
Published Date: 6 December 2025